South African baby-snatcher sentenced to 10 years in jail
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
CAPE TOWN (Reuters) - A South African woman found guilty of kidnapping a newly-born baby was given a 10 year prison sentence on Monday, almost two decades after she snatched the child from her biological mother’s hospital bedside, a court official said.
The 51-year-old woman, who cannot be named to protect the identity she gave to baby “Zephany Nurse”, was arrested in 2015 after suspicions were raised when pupils at her school remarked on her close resemblance to another girl.
DNA tests carried out by police then proved that the two girls were sisters, ending 19 years of uncertainty for biological parents, Celeste and Morne Nurse.
Prosecutors wanted the Cape High Court to impose a 15-year sentence on the accused. She was found guilty of kidnapping, fraud and contravening the Children’s Act.
"I can confirm that the accused in this case has been sentenced to 10 years direct imprisonment. We are happy with that sentence," said Eric Ntabazalila, a regional spokesman for the National Prosecuting Authority.
(Reporting by Wendell Roelf; Editing by Joe Brock)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Afghan president says Taliban wouldn't last a month without Pakistan support
- Trump conversation with Taiwan president a 'courtesy call': Pence
- British PM May cracks down on Brexit leaks: Mail on Sunday
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!